|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| IgG Deficiency | |||||
| Infections | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Communicable Diseases | |||||
| Infection | |||||
| 3 | More general conditions related to this trial | ||||
| Blood Protein Disorders | |||||
| Dysgammaglobulinemia | |||||
| Hematologic Diseases | |||||
| Immune System Diseases | |||||
| Immunologic Deficiency Syndromes | |||||
| 4 | Interventions listed in this trial | ||||
| IV Gamunex 10% | |||||
| 5 | Sponsors listed in this trial | ||||
| The Center for Rheumatic Disease, Allergy, &Immunology | |||||
| Talecris Biotherapeutics | |||||